References
- Ashell G, Harford J. 1982. Carbohydrate-specific receptors of the liver. Annu Reu Biochem. 51:531–554.
- Jeong YI, Seo SJ, Park IK, Lee HC, Kang IC, Akaike T, Cho CS. 2005. Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(gamma-benzyl-l-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int J Pharm. 296:151–161.
- Liang MH, Ma Z, Wang ZY, Shen ZR. 2011. Synthesis and characterization of n-galactosylated-chitosan-5-fluorouracil acetic acid conjugate. Chin Pharm J. 46:1677–1680.
- Liang MH, Shen ZR, Ma Z, Wang ZY. 2010. Progress on ASGPR- mediated hepatic targeting. Chin J Mod Appl Pharm. 2:109–114.
- Park IK, Yang J, Jeong HJ, Bom HS, Harada I, Akaike T, et al. 2003. Galactosylated chitosan as a synthetic extracellular matrix for hepatocytes attachment. Biomaterials. 24:2331–2337.
- Park YK, Park YH, Shin BA, Choi ES, Park YR, Akaike T, Cho CS. 2000. Galactosylated chitosan-graft-dextran as hepatocyte-targeting DNA carrier. J Controlled Release. 69:97–108.
- Pricer WE, Ashwell G. 1971. The binding of desialylated glycoproteins by plasma membranes of liver. J Biol Chem. 246:4825–4833.
- Rao SB, Sharma CP. 1997. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res. 34:21–28.
- Rensen PC, Herijgers N, Netscher MH, Meskers SC, Eck M, Berkel TJ. 1997. Particle size determines the specificity of apolipoprotein e-containing triglyceride-rich emulsions for the ldl receptors versus hepatic remnant receptor in vivo. J Lipid Res. 38: 1070–1084.
- Sandford P. 1989. Chitosan: commercial uses and potential applications. Skjåkbraek G, Anthonsen T, Sandford P, Eds. Chitin and Chitosan. London, UK: Elsevier Applied Science, pp. 51–69.
- Suzuki K, Tokoro A, Okawa Y, Suzuki S, Suzuki M. 1986. Effect of N- acetylchito-oligosaccharides on activation of phagocytes. Microbiol Immunol. 30:777–787.